Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRSS48 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
mRNA | SPTBN4 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
mRNA | AC007192.4 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
mRNA | FBLN5 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
mRNA | BAGE5 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
mRNA | CBY3 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
mRNA | NAT14 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
mRNA | IER3IP1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | PMPCA | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
mRNA | EDIL3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |